In response to the fast-growing number of COVID-19 research projects, new and enhanced research data tools and data sets are being made available to support these endeavors. The goal is to support the rapid turnover of analytics to help researchers understand the signs and symptoms, comorbidities, and treatments of COVID-19. Please visit https://rc.partners.org/COVIDResearch for full details and updates.
-
COVID-19 Tools in Collibra
- Collibra provides researchers a common language for RISC data assets across data repositories in a single location. Details of these data assets are structured within a series of dashboards containing relevant information, how to access, security and compliance, and data dictionary links.
-
COVID-19 Data Mart housed in the Data Enclave
- For access to the Data Enclave, complete form Research Access Request
-
COVID-19 Summary File
-
For access to the COVID-19 Summary File, complete the Research Access Request.
- The COVID-19 Summary File is an easily accessible spreadsheet that contains summary information on the COVID-19 patient cohort. The pre-defined concepts allow for a quick review of important patient elements for COVID-19 research.
-
-
RPDR (Research Patient Data Registry) COVID-19 patient data updated daily
- The RPDR Daily Query Tool includes the following COVID-19 laboratory tests updated DAILY. Patients tested for COVID-19 from the previous day can be identified and data requested.
- What Data is Available?
- SARS coronavirus RNA/PCP lab tests;
- COVID-19 test comments;
- COVID-19 lab order result statuses; and
- COVID-19 specimen sources.
-
Biobank Portal COVID-19 defined patients with genomic information
- The Biobank Portal is a web-based query tool that allows Partners investigators to query and download data about consented Biobank subjects. You can also make Biobank sample requests for plasma, serum, DNA, and genomics data directly from the portal.
COVID-19 Research support email: MGBCOVIDResearchRequest@partners.org
Please visit https://rc.partners.org/COVIDResearch for details and updates.